Condition 1: -. Condition 2: -. - -
Conditions
Interventions
Treatment - Drugs
Placebo
Sponsors
Vice President of Research Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria :1) Menopausal women, 2) Women willing to cooperate in this study and presented their written consent form, 3) These women should not suffer from diseases related to liver, kidney, thyroid, parathyroid, intestine and bone…… in which they receive special medicines which affect the bone density, 4)They should not use any kinds of hormonal medicines, 5) Menopausal women who are osteopanic and receive supplementary Calcium and vitamin D, but they do not receive treatment with other with other effective hormonal medicines which affect the bone density (these medicines are mostly used by osteoprose patients), 6) They should not be sensitive to herbal medicines. .Exclusion criteria:1) Allergic reaction to medicine, 2) Detection of a patient, during the study, who needs to use the medicine effective on bone density.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Osteogenic factors. Timepoint: At the beginning and end of the study. Method of measurement: Blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical and emotional symptoms. Timepoint: At the beginning and end of the study. Method of measurement: the questionnaire about Menopause Rating Scale(MRS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmarzieh akbarzadeh
Shiraz University of Medical Sciences
Outcome results
None listed